These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 13512101)
41. [On the combined use of adonis vernalis with cardiac glycosides and strophanthin derivatives in treating patients with circulatory insufficiency]. Gubergrits AIa; Leshchinskiĭ LA Sov Med; 1968 Jan; 31(1):23-7. PubMed ID: 5691025 [No Abstract] [Full Text] [Related]
42. [Clinical observations in the therapy with cardiac glycosides]. PATZ A Arztl Wochensch; 1952 Apr; 7(17):392-4. PubMed ID: 12976228 [No Abstract] [Full Text] [Related]
43. [Observations on the use of proscillaridin A in some disorders of cardiac rhythm]. Greco M Clin Ter; 1967 Jun; 41(6):555-60. PubMed ID: 5629057 [No Abstract] [Full Text] [Related]
44. [Cardiac glycosides from the white sea onion or squill. The constitution of the scilliphäeosides and glucoscilliphaeosides]. von Wartburg A; Kuhn M; Huber K Helv Chim Acta; 1968; 51(6):1317-28. PubMed ID: 5680740 [No Abstract] [Full Text] [Related]
45. Siberian ginseng toxicity may be case of mistaken identity. Awang DV CMAJ; 1996 Nov; 155(9):1237. PubMed ID: 8964001 [No Abstract] [Full Text] [Related]
46. Novel therapeutic applications of cardiac glycosides. Prassas I; Diamandis EP Nat Rev Drug Discov; 2008 Nov; 7(11):926-35. PubMed ID: 18948999 [TBL] [Abstract][Full Text] [Related]
49. [Regulation of the therapeutic and toxic effect of cardiac glycosides by electromagnetic radiation, alternating magnetic, and electric fields]. Grechko AT Biull Eksp Biol Med; 1994 Nov; 118(11):502-4. PubMed ID: 7888651 [No Abstract] [Full Text] [Related]
50. [Indications and contraindications for therapy with cardiac glycosides]. Haasis R Fortschr Med; 1982 Aug; 100(31-32):1436-9. PubMed ID: 7129303 [TBL] [Abstract][Full Text] [Related]
51. [Recent acquisitions in the study of the pharmacology of cardiac glycosides. Pharmacokinetic approach to therapy with cardiac glycosides]. Lesne M J Pharm Belg; 1973; 28(2):217-33. PubMed ID: 4733470 [No Abstract] [Full Text] [Related]
52. [Do patients with chronic kidney failure need cardiac glycosides?]. Konstantinov IuV; Shulutko BI; Tsanava KA; Konstantinova IV Ter Arkh; 1992; 64(10):114-7. PubMed ID: 1485239 [No Abstract] [Full Text] [Related]
53. [Prophylactic use of cardiac glycosides in patients with ischemic heart disease]. Komarov FI; Rabkin IKh; Ol'binskaia LI; Kitaeva IT; Abugov AM Ter Arkh; 1974; 46(9):29-35. PubMed ID: 4439302 [No Abstract] [Full Text] [Related]
54. [Experiences with an intravenously administered Crataeugus preparation]. VON LOEWENSTEIN O Med Monatsschr; 1956 Jan; 10(1):26-7. PubMed ID: 13296853 [No Abstract] [Full Text] [Related]
55. [On the specific treatment of senile cardiac insufficiency]. Köhler U Landarzt; 1965 Jan; 41(3):122-4. PubMed ID: 5890170 [No Abstract] [Full Text] [Related]
56. [Importance of digitalemia for a correct therapeutic attitude using cardioactive glycosides]. Pretolani E; Baraghini F; Zoli I Quad Sclavo Diagn; 1975 Jun; 11(2):266-71. PubMed ID: 1223938 [TBL] [Abstract][Full Text] [Related]
57. [Effectiveness of the combined use of cardiac glycosides and de-aggregating agents in chronic pulmonary cardiac insufficiency]. Dudka PF Vrach Delo; 1980 Apr; (4):26-8. PubMed ID: 7385768 [No Abstract] [Full Text] [Related]
58. [Clinical trial of a new cardiac glycoside: cd.412]. Gentile C; Gentile JH Prensa Med Argent; 1972 Jun; 59(22):841-8. PubMed ID: 5051118 [No Abstract] [Full Text] [Related]
59. [The importance of cardiac glycoside therapy. Digitalis--to use or not to use?]. Jerie P Ther Umsch; 1984 Feb; 41(2):96-102. PubMed ID: 6369617 [No Abstract] [Full Text] [Related]